Neuroimaging – News and Features

A UT Southwestern study finds that higher cardiorespiratory fitness may slow age-related brain atrophy, preserving cognitive function. The study showed that those with better physical fitness had larger brain volumes and better cognitive performance.

Researchers at Massachusetts General Hospital developed a novel cannula delivery system for effective compound administration during multiphoton microscopy, allowing for extended in vivo brain imaging.

Researchers have developed a treatment for Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them into patients. Early results show the treatment is safe and may improve Parkinson’s symptoms.

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery.

A new USC study reveals how gut-derived metabolites influence brain activity and autism-related behaviors. The research supports a gut-brain-behavior connection in ASD, suggesting that metabolites impact brain regions associated with emotion.

Researchers from Queen Mary University of London have developed an AI tool that creates synthetic yet medically accurate models of fibrotic heart tissue (heart scarring), aiding treatment planning for atrial fibrillation patients.

Researchers have developed a new AI tool, VisionMD, that can help doctors to more accurately monitor subtle motor changes, improving treatment for patients with Parkinson's disease and other movement disorders.

According to a new modeling study, the high number of CT (computed tomography) scans carried out in the United States in 2023 could cause 5 percent of all cancers in the country, equal to the number of cancers caused by alcohol.

Researchers identified a neural circuit defect in ASD that impairs the ability to redirect attention, crucial for social learning. The study suggests that interventions targeting this circuit could help improve attention-switching in ASD children.

A UCLA-led study reveals that children with chromosome 22q11.2 deletion syndrome show brain hyperconnectivity before puberty and under-connectivity after. This shift, linked to synapse loss, may drive autism and schizophrenia risk.